Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Primary Care
•
General Primary Care
•
Women
What is your approach when counseling patients interested in bio-identical hormones for management of menopause versus traditional hormone replacement therapy?
Related Questions
Do you start bisphosphonates after tapering off menopausal hormone therapy to prevent the rapid decline of bone mineral density?
What symptom or constellation of symptoms are most specific for endometriosis that should prompt further workup?
How do you decide whether average-risk patients should undergo annual or biennial breast cancer screening?
What strategies do you find most helpful when discussing recommendations for ongoing COVID-19 vaccinations?
Other than oxybutynin or mirabegron, what pharmacological and non-pharmacological treatments would you consider for increased urinary frequency (not caused by infection, medications, or resulting in incontinence)?
How do you reconcile the risk of contrast-induced nephropathy (CIN) with the diagnostic benefit of contrasted CT in patients with AKI/CKD?
Do you counsel patients to take antihypertensives at specific times of day to maximize efficacy or minimize side effects?
Do you still prescribe a statin for patients with diabetes on GLP-1s for cardiovascular risk reduction if their LDL is at goal?
What is your approach to a situation where DILI is suspected secondary to an important medication (e.g., anticoagulation, antibiotics, etc.), but the diagnosis is uncertain and the liver injury is relatively mild?
How do you approach balancing the risks and benefits of elective surgery with patients who have multiple co-morbidities (e.g., frailty, chronic kidney disease, and COPD), when standard risk calculators do not capture the full complexity of their condition?
